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A B S T R A C T
The objective of this study was to analyze how preoperative glucose treatment influences the blood glucose level as a
measured exponent of surgical stress and to establish the best postoperative replacement considering glucose solutions
and insulin. This prospective clinical trial involved 208 non-diabetic patients with normal glucose tolerance, who under-
went major surgical procedures and needed 24 hours ICU monitoring postoperatively. Patients were randomly given 5%
glucose solution (1000 mL) one day before surgery or after overnight fasting. Group A and group B were randomized to
be given 5 different kinds of postoperative replacement with cristalloids and insulin. None of the patients from group A
or group B were given glucose solutions during surgical procedures. Blood glucose levels were measured 14 times from
the preoperative period until 24 hours after admission to the ICU and the main outcome measure was blood glucose level.
All patients had a statistically significant increase in blood glucose levels in comparison to basal levels (p<0.05) in all
measurements. All data were processed with descriptive statistics, chi-square test, parametric ANOVA test and ANOVA
test with repeated measure, non parametric Kruskal-Wallis test and Mann-Whitney U-test. Statistically significant change
was accepted with p<0.05. Preoperative glucose infusion decreased metabolic and endocrine response only during sur-
gery; the smallest increase of postoperative blood glucose level was noticed after administering postoperative non-glucose
crystalloid solutions; there is no clinical evidence that one specific postoperative replacement is better than the other;
there is no clinical evidence that postoperative use of insulin can decrease or attenuate surgical induced insulin resis-
tance.
Key words: glucose metabolism, postoperative insulin resistance, preoperative feeding, preoperative glucose infu-
sion, surgical stress
Introduction
Human metabolic and endocrine response to stress is
the same as during an operative procedure1. One of the
most important physiological tasks is to protect the blood
glucose level, as the only energy source. Hyperglycaemic
response is a common finding in all patients with poly-
trauma, patients who undergo major surgical procedures
and usually occurs as a result of mobilization of energy
stores after increases of cortisol and other regulative
hormones2,3.
Basal blood glucose levels are kept in a narrow range,
mainly by food ingestion. During fasting, glucose re-
serves in the form of glucagon are expendable in 24 hours
and every new stress is potentially dangerous. Such hy-
poglycaemia leads to metabolic disbalance and deteriora-
tion of the mental state, even in healthy individuals with
intact regulatory mechanisms. To prevent mobilization
of proteins and fat, regulatory mehanisms utilize all of
the stored glucose with temporary hyperglycaemia as a
consequence4.
As a result of major surgical procedures glucose utili-
zation on cell membrane occurs as a disorder of impor-
tant metabolic functions. Surgically induced postopera-
tive insulin resistance sometimes increases hyperglycae-
mia to pathological levels, even though temporarily high
blood glucose levels serve as a defense mechanism.
Anaesthesia and analgesia decrease metabolic and en-
docrine responses to major surgical procedures, attenu-
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ate postoperative insulin resistance and improve glucose
transport and utilization on cell membranes and stop the
increase of blood glucose levels5.
Infusion of glucose and other solutions are common
and necessary procedures in patients who undergo sur-
gery because of volume depletion and energy loss during
the preoperative period and the surgical procedure it-
self6. The best way to prevent metabolic disturbances
due to preoperative fasting and major surgical proce-
dures as precipitants of major stress, is well planned
perioperative administering of glucose solutions and in-
sulin7,8. There is a lot of data about postoperative infu-
sion of glucose solutions and insulin, but it still necessary
to further ellucidate and explain their roles, especially
the regulatory role of insulin in postoperative hyper-
glycemia9,10.
The aim of the study
The aim of the study is to analyze the effect of preop-
erative glucose infusions on blood glucose levels as a
measured exponent of surgical stress and to help answer
the question of what is the best postoperative modality
for the replacement of volume, electrolites, energy and




After written consent and approval of the Hospital
Ethical Committee, 220 nondiabetic patients who under-
went major surgical procedures and needed ICU moni-
toring the following 24 hours or more, were included in
this prospective study. The surgical procedures were ma-
jor surgical procedures which lasted for more than 2
hours. There is no evidence of previously defective glu-
cose tolerance in any of the patients included in our clini-
cal trial. Patients were randomly given 5% glucose solu-
tions (1000 mL) one day before the operation or after
overnight fasting. Group A and group B were randomly
given non-glucose crystalloid solutions, glucose solutions
or glucose solutions with insulin postoperatively. None of
the patients were given glucose solutions during the sur-
gical procedure.
Clinical trial protocol:
Blood samples for laboratory testing of blood glucose
levels were taken during:
1. anaesthesiologic examination
2. preoperatively, on the day of surgery
3. immediately after induction of anaesthesia before
surgical incision
4. two hours after the begining of anaesthesia
5. at the end of the operation
6. 3 hours after admission to ICU
7. every 3rd hour during treatment in the ICU
8. 24 hours after admission to the ICU
All drugs for induction and anaesthesia maintenance
(thiopental, propofol, midazolam, etomidate, leptosuccin,
pancuronium bromide, fentanyl) and postoperative anal-
gesia (tramadol) were used in all patients in the recom-
mended doses per kg/body mass. The experimental pro-
cedure was interrupted on occurence of hypoglycemia
(<3 mmol/L) or hyperglycaemia (>15 mmol/L).
Statistics
Twelve patients weren’t included in statistical pro-
cessing because they received extra doses of insulin for
postoperative hyperglycaemia correction in the ICU, as
the experimental protocol design proposed. Patients who
had hyperglycemia higher than 15 mmol/L were inclu-
ded, but they did not receive extra doses of insulin be-
cause the anaesthesiologist in the ICU considered that at
that time there was no danger to patients and such high
blood glucose levels are temporary. Finally, statistical
group A had 90 and group B 118 examinees. Every sub-
group had more than 30 patients.
All data were processed with descriptive statistics and
chi-square test between and within groups and sub-
groups. There were no significant differences found, so
the findings were fully comparable. For further statistics,
parametric ANOVA test and ANOVA test with repeated
measure, non parametric Kruskal-Wallis test and Mann-
-Whitney U-test were used.. Statistically significant chan-
ges were accepted with p<0.05.
Results
All data are presented with tables and figures. The
blood glucose data which was taken from blood samples
and was calculated as a mean value from several mea-
surements, has ordinal numbers which are used in tables
and charts:
1. blood glucose level at anaesthesiologic examination
2. preoperative blood glucose level, on the day of sur-
gery
3. blood glucose level immediately after induction of
anaesthesia, before surgical incision




group A – preoperative
infusion of 5% glucose
solution (1000 mL)
group B – preoperative
overnight fasting
Subgroup I normal saline, 1500 mL and Ringer’s solution,
1000 mL
Subgroup II 5% glucose solution, 1500 mL and Ringer’s so-
lution, 1000 mL
Subgroup III 5% glucose solution + 8 IU of insulin per 500
mL of glucose solution, 1500 mL and Ringer’s
solution, 1000 mL
Subgroup IV 10% glucose solution + 8 IU of insulin per 500
mL of glucose solution, 1500 mL and Ringer’s
solution, 1000 mL
4.blood glucose level two hours after the begining of
anaesthesia
5.mean blood glucose level during anaesthesia and
surgical procedure
6.blood glucose level 3 hours after admission to the
ICU
7.blood glucose level 6 hours after admission to the
ICU
8.blood glucose level 9 hours after admission to the
ICU
9.blood glucose level 12 hours after admission to the
ICU
10.blood glucose level 15 hours after admission to the
ICU
11.blood glucose level 18 hours after admission to the
ICU
12.blood glucose level 21 hours after admission to the
ICU
13.blood glucose level 24 hours after admission to the
ICU
14.mean blood glucose level during treatment in the
ICU
Discussion
Many studies have showed that the human organism
responds in the same manner to immediate danger, tra-
uma, stress or surgical procedure11,12.Our study shows
that one easily measured, but very sensitive mediator of
homeostasis such as blood glucose level, can answer some
questions and prevent some metabolic disturbances as
negative consequences of surgical trauma.
All of our patients had statistically significant in-
creases in blood glucose levels, in comparison to basal
levels (p<0.05). Surgically induced hyperglycaemia occu-
red as a consequence of cortisol activity and other regula-
tory hormones, as a protection mechanism of glucose re-
serves during surgical trauma, which correlates with
other authors data13. Postoperative hyperglycaemia seems
to be a result of insulin resistance more than the before
mentioned protective mechanism14,15. Surgically induced
insulin resistance was apparent after 24 hours from the
beginning of our trial and persisted for 5 days, the blood
glucose level was 23% higher than basal blood glucose
levels, without respect to group or subgroup16. Previous
data suggest that oscillations in insulin activity are not
influenced only by increasing activity of stress hormo-
nes17. Volume, electrolites and energy reserves through
infusion are necessary in every major surgical procedure,
but there is still some doubt about perioperative use of
glucose solutions18,19.
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Fig. 1. Mean blood glucose level.
Fig. 2. Group A – mean blood glucose level in subgroups.
Fig. 3. Group B – mean blood glucose level in subgroups.
TABLE 1
GENERAL DATA
Group A Group B All
Male 66 (42.04%) 91 (57.96%) 157
Female 24 (47.06%) 27 (52.94%) 51
All 90 118 208
Subgroup I 17 22 39
Subgroup II 18 19 37
Subgroup III 17 21 38
Subgroup IV 17 20 37
Subgroup V 21 36 57
All 90 118 208
Age 60.24 ± 11.92 godina 61.22 ± 10.57 godina
Weight 73.15 ± 12.45 kg 75.38 ± 14.04 kg
Height 170.46 ± 8.47 cm 171.45 ± 9.01 cm
Basal blood glucose level is 5.5 mmol/L and the highest physio-
logical blood glucose level is set according to the hospital bio-
chemical laboratory.
There is no clinical evidence from large and meta
studies that would support the fact that intraoperative
infusion of glucose would be more harmful than other
crystalloid non-glucose solutions, but following the rule
»primum non nocere«, all clinicians administer non-glu-
cose infusions during surgical procedures20,21. Preopera-
tive fasting, without glucose infusions during long opera-
tions and different approaches to postoperative glucose
compensation cause metabolic and immune disturbances
in many patients and this problem challenges investiga-
tors to find a way to decrease these negative manifesta-
tions. Preoperative treatment with glucose infusions sho-
wed some clinical benefits for patients who underwent
major surgery22.
In Table 2. are shown the mean, minimal and maxi-
mal blood glucose values during our experiment. In group
B, the amplitude of glucose values shows more variations
than in group A and that finding supports the hypothesis
of stabilizing blood glucose levels with preoperative glu-
cose infusions23. Patients in group B have a much higher
increase in blood glucose levels only during the surgical
procedure and with a statistical significance compared to
group A (p<0.05). We concluded that preoperative glu-
cose treatment attenuated metabolic and endocrine hu-
man responses during major surgery24.
We did not include the changes in postoperative insu-
lin resistance as an observed parameter in our clinical
trial. Some authors show that it exists but besides clini-
cal parameters, they used psychological, social and med-
ico-economic parameters (discomfort, length of stay in
the ICU and the hospital, the outcome) in their survey25.
Some findings in postoperative measurements (Table 3.)
can be misleading. From our data, we concluded that sta-
tistically significant differences between groups with re-
spect to subgroups, which is seen in some postoperative
measurements, is influenced by inadequate analgesia
and does not correlate to preoperative glucose infusions26.
We are convinced that our statement is valid because the
significant difference in blood glucose levels occured in
the first measurements taken in the ICU at time when
intraoperative analgesia is reduced and postoperative is
not adequately managed. Significant differences in in-
crease occured in both groups, which proves that preop-
erative glucose infusion is not responsible for these chan-
ges. For all patients in subgroups II and III, preoperative
glucose usage evidently produced a statistically signifi-
cant difference in blood glucose levels with respect to
subgroup I in which for postoperative compensation, pa-
tients only had non-glucose crystalloid solutions. Statis-
tically significant difference in blood glucose level be-
tween subgroups is seen in group A, in every subgroup
which, for postoperative replacement, has a glucose solu-
tion (subgroup II) and glucose solution with insulin (sub-
group III,IV,V). The data are presented in Table 4. There
are no significant differences in group B, which suggests
that postoperative glucose can be utilized only if a suffi-
cient dose of insulin exists. That correlates with the find-
ings in literature that surgically induced insulin resis-
tance is, mediated through interference with glucose
utilization on cell membranes and fat and protein metab-
olism as the main reasons of postoperative hypergly-
caemia27. Previous data shows that an 8 times higher in-
sulin dose is necessary to maintain postoperative glycaemia
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TABLE 2
BLOOD GLUCOSE LEVELS AT THE TIME OF MEASUREMENT
Time
Group A Group B
Min median max min median max
1 3.7 5.4 8.5 3.7 5.3 7.8
2 3.6 5.1 7.6 3.2 5.1 14.4
3 2.9 5.6 15.4 2.9 5.4 12.7
4 4.1 6.9 15.4 4.8 7.1 20.3
5 4.1 6.6 15.4 4.8 6.75 17.6
6 4.1 7.3 14.3 4.6 8.45 21
7 4.4 9.7 19.6 5.3 9.5 22
8 4.1 9.6 18.4 4.6 8.85 24
9 2.5 8.4 24.1 3.1 8.2 30
10 3.8 7.55 19.3 2.1 7.6 27.8
11 3.7 7.15 16.2 3 7.1 30.5
12 2.3 6.75 12.3 4.1 7 21.8
13 3.3 6.55 11.5 4.1 6.5 14.2
14 4.7 8.2 12.5 5.1 8.1 19.7
TABLE 3
BLOOD GLUCOSE LEVEL AND STATISTICAL SIGNIFICANCE BE-
TWEEN GROUPS
Group A Group B p – level











Time 6 7.1 8.5 0.0252
Subgroup IV
Time 8 11 8.65 0.0434
Subgroup V
Time 8 9.55 8.3 0.0345
TABLE 4




A + B Group A Group B
I :II 0.0356 0.0132 NS
I : III 0.0109 0.0087 NS
I : IV NS 0.0252 NS
I : V NS 0.0116 NS
NS – non-sprecific
at preoperative values, that glucose utilization is 100%
and all of the mentioned strongly proves that postopera-
tive insulin doses used in our clinical trial are insufficient
and inadequately regulated and do not influence surgi-
cally induced insulin ineffectivness28. Some other studies
show that perioperative infusion of glucose and insulin
can diminish surgical stress and future investigations
have to answer which is the adequate dose29.
Conclusion
The results of our clinical trial were thoroughly com-
pared with available data from literature and we conclu-
ded that use of preoperative glucose infusion is beneficial
to patients because it decreases metabolic and endocrine
responses and maintains blood glucose levels in narrow
limits, especially during surgery; use of non-glucose cry-
stalloid solutions is the best way for postoperative vol-
ume, electrolite and energy replacement because the
smallest increase of blood glucose levels is seen with such
infusions; there is no clinical evidence that some specific
replacement is better for patients than another; there is
no clinical evidence that postoperative use of insulin can
decrease or attenuate surgically induced insulin resis-
tance and ineffectivness; postoperative pain must be
carefully monitored and adequately treated in order to
prevent the aggravation of consequences from surgical
trauma.
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PERIOPERATIVNA PRIPREMA GLUKOZOM I INZULINOM
S A @ E T A K
Razina glukoze u krvi je va`an pokazatelj stresnog odgovora tijekom i nakon operacije. Istra`ivanje je provedeno na
208 pacijenata koji su nakon velike operacije zahtijevali 24 satni boravak u jedinici intenzivnog lije~enja. Prije i poslije
operacije ispitanicima su slu~ajnim odabirom davane otopine 5% glukoze ili kristaloidne otopine. Razina glukoze u krvi
mjerena je prije, tijekom i poslije operacije. Pokazali smo da je prijeoperacijski davanje glukoze korisno u smislu smanje-
nja metaboli~kog i endokrinog stresnog odgovora te odr`avanja razine {e}era u krvi u uskim granicama. Nema dokaza
da poslijeoperacijsko davanje otopina glukoze uz inzulin smanjuju kirur{ki uzrokovanu poslijeoperacijsku inzulinsku
rezistenciju.
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